CSPC Pharmaceutical: Vitamin C Revenues Reach 1.994 Billion in 2024, Up 3.4% Year-on-Year

North China Pharmaceutical Reports Net Profits of RMB 127 Million in 2024, Reflecting a Substantial Year-on-Year Increase

Fufeng Group Reports 2024 Net Profits of 2.312 Billion, Down 26.5% Year-on-Year

Stable Demand and Weakening Prices

98% L-Lysine HCL Prices Slightly Drop While Threonine Prices Firmly Stabilize in China; Many Methionine Factories Announce Maintenance Schedules

China’s Vitamin Market Remains Stable with Downstream Buyers Approaching Procurement Cautiously and Some Factories Lifting Niacinamide Prices

Tryptophan Prices Drop Evidently in China Amid Market Focus on Core Producers’ Month-End Quotes

China’s Vitamin Market Remains Subdued, with Factories for Vitamins A, E, and B3 Suspending Quotes and Orders

Dicalcium Phosphate Market Consolidates at Elevated Levels, Sodium Bicarbonate Prices Edge Down, While Whey Powder Prices Remain Stable

Garden Biopharmaceutical’s 2024 Net Profits Surge by 60.76% Year-on-Year